Alembic Pharma Notifies Loss of Equity Share Certificate

Alembic Pharmaceuticals Limited has issued a notice regarding the loss of an equity share certificate. The certificate, bearing number 13361 and covering 720 shares for shareholder Bollam Sivaprasad (...

Alembic Pharmaceuticals Limited has issued a notice regarding the loss of an equity share certificate. The certificate, bearing number 13361 and covering 720 shares for shareholder Bollam Sivaprasad (Folio No. 0076542), has been reported as lost or misplaced. The company has received an application for the issuance of a duplicate share certificate. A public warning has been issued against purchasing or dealing with these shares. Any person with a claim regarding these shares must submit full details with documentary evidence to the Company's Registrar and Transfer Agent (RTA), MUFG Intime India Private Limited, or the company's registered office within 15 days of the notice publication date. Failure to do so will result in the issuance of duplicate shares without further notice. The notice was published in the Business Standard newspaper on December 25, 2025, with the application for duplicate shares dated December 24, 2025.

Limitations of AI summaries

AI models can summarize market news but cannot assess portfolio-specific impact or simulate investment scenarios.

Platforms like Prysm provide stock-level and portfolio-level analysis.

Why is Alembic Pharmaceuticals Limited in the news today?

Alembic Pharmaceuticals Limited (APLLTD) is in the news due to the announcement is a routine regulatory filing regarding a lost share certificate and does not contain any information that positively or negatively impacts the company's financial performance or business operations.

Loss of Share CertificateOther Regulatory Filings
Alembic Pharmaceuticals LimitedAPLLTDhttps://prysm.fi/v2/analyze/APLLTD

AI-Powered Summary

Market Context

Top Queries

More News

Explore Prysm Tools

Related Stories

Alembic Pharma Notifies Loss of Equity Share Certificate

December 25, 2025, 10:31 AM

AI Sentiment Analysis

Top Queries to Ask About Alembic Pharmaceuticals Limited

Alembic Pharmaceuticals Limited has issued a notice regarding the loss of an equity share certificate. The certificate, bearing number 13361 and covering 720 shares for shareholder Bollam Sivaprasad (Folio No. 0076542), has been reported as lost or misplaced.

The company has received an application for the issuance of a duplicate share certificate.

A public warning has been issued against purchasing or dealing with these shares. Any person with a claim regarding these shares must submit full details with documentary evidence to the Company's Registrar and Transfer Agent (RTA), MUFG Intime India Private Limited, or the company's registered office within 15 days of the notice publication date. Failure to do so will result in the issuance of duplicate shares without further notice. The notice was published in the Business Standard newspaper on December 25, 2025, with the application for duplicate shares dated December 24, 2025.

See What Deep Dive Gives You — in Seconds

“what happens when you click Deep Dive “

Instant AI Summary - “Get clean, noise-free earnings breakdowns.”

PDF Insights - “Download detailed, AI-generated reports.”

Metrics Explained -“Key ratios & trends explained in simple language.”

Want to know if this news pushes your stock up or down?

Just tap

deep dive

More News on Alembic Pharmaceuticals Limited

Discover more trending news on Prysm

View All